Cannell Capital Q2 2022 holdings

$498 Million is the total value of Cannell Capital's 90 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was - .

 Value Shares↓ Weighting
TDW NewTIDEWATER INC NEW$9,507450,780
+100.0%
1.91%
CVCO NewCAVCO INDS INC DEL$3,23916,524
+100.0%
0.65%
NewDIAMOND OFFSHORE DRILLING IN$3,094525,283
+100.0%
0.62%
PWFL NewPOWERFLEET INC$2,2221,023,990
+100.0%
0.45%
LINC NewLINCOLN EDL SVCS CORP$2,018319,848
+100.0%
0.40%
BNED NewBARNES & NOBLE ED INC$598203,974
+100.0%
0.12%
NewYANDEX N V$4811,830
+100.0%
0.10%
NewTWITTER INC$1083,995
+100.0%
0.02%
BOIL NewPROSHARES TR IIultra bloomberg$451,063
+100.0%
0.01%
OVID NewOVID THERAPEUTICS INC$135,949
+100.0%
0.00%
BNR NewBURNING ROCK BIOTECH LTDsponsored ads$154,984
+100.0%
0.00%
NewXILIO THERAPEUTICS INC$134,545
+100.0%
0.00%
FSTX NewF-STAR THERAPEUTICS INC$111,804
+100.0%
0.00%
NewPARDES BIOSCIENCES INC$123,959
+100.0%
0.00%
NewOMEGA THERAPEUTICS INC$102,738
+100.0%
0.00%
NewIO BIOTECH INC$102,192
+100.0%
0.00%
FIXX NewHOMOLOGY MEDICINES INC$115,753
+100.0%
0.00%
SBTX NewSILVERBACK THERAPEUTICS INC$112,569
+100.0%
0.00%
OMIC NewSINGULAR GENOMICS SYSTEMS IN$123,014
+100.0%
0.00%
GRPH NewGRAPHITE BIO INC$113,952
+100.0%
0.00%
GRCL NewGRACELL BIOTECHNOLOGIES INCsponsored ads$122,189
+100.0%
0.00%
GBIO NewGENERATION BIO CO$111,745
+100.0%
0.00%
GANX NewGAIN THERAPEUTICS INC$102,751
+100.0%
0.00%
CYT NewCYTEIR THERAPEUTICS INC$123,891
+100.0%
0.00%
NewTSCAN THERAPEUTICS INC$113,654
+100.0%
0.00%
NewVIGIL NEUROSCIENCE INC$93,636
+100.0%
0.00%
AUTL NewAUTOLUS THERAPEUTICS PLCspon ads$114,001
+100.0%
0.00%
LVTX NewLAVA THERAPEUTICS NV$124,058
+100.0%
0.00%
NewADAGIO THERAPEUTICS INC$113,357
+100.0%
0.00%
ADAG NewADAGENE INCads$115,285
+100.0%
0.00%
ANGN NewANGION BIOMEDICA CORP$76,109
+100.0%
0.00%

The following EDGAR filing(s) were analyzed to create this report:

The EDGAR filing(s) were signed by:

  • J. Carlo Cannell — Managing Member of Cannell Capital LLC

Compare quarterly holdings

Export Cannell Capital's holdings

EDGAR filings